Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-072516
Filing Date
2025-07-31
Accepted
2025-07-31 09:06:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2522111d1_defa14a.htm DEFA14A 12988
2 GRAPHIC tm2522111d1_defa14aimg001.jpg GRAPHIC 6227
  Complete submission text file 0001104659-25-072516.txt   22971
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 251169689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)